“…For example, transient receptor potential vanilloid-1 (TRPV1) has been found to be an important transducer of chemical, inflammatory, and neuropathic pain signals, and is expressed in a variety of neuronal and non-neuronal tissues and organs, including chondrocytes, fibroblasts, macrophages, and the dorsal root ganglion (DRG), which play an important role in inflammatory diseases such as OA and rheumatoid arthritis [ 73 , 74 ]. Transient receptor potential vanilloid-4 (TRPV4) has been shown to respond directly or indirectly to a variety of mechanical signals, such as stretch, compression, osmotic pressure, and shear stress [ 75 ]. Recently, functional changes in TRPV1 and TRPV4 channels have been identified as risk factors for OA, and their abnormal expression and function can cause cell necrosis and apoptosis, cartilage extracellular matrix degradation, synovial inflammatory response, and hyperalgesia [ 76 , 77 , 78 ], suggesting that TRPV1 and TRPV4 play an important role in OA pain generation as well as disease progression.…”